Ben Casavant, PhD, CEO & Co-Founder of Tasso Inc. The collaboration positions Neurogen at the forefront of globally building a scalable, home-based model for Alzheimer’s-related biomarker testing and ...
SEATTLE--(BUSINESS WIRE)--Tasso Inc., a pioneer in clinical-grade, at-home, self-sampling blood collection, today announced it has completed an oversubscribed $17 million Series A financing round. The ...
MORRISVILLE, N.C.--(BUSINESS WIRE)-- Q2 Solutions, a wholly-owned subsidiary of IQVIA and a leading clinical trial laboratory services organization, today announced a transformative collaboration with ...
Athlete-centric blood collection joint offering returns for its second Olympic Games as demand for modern anti-doping solutions intensifies worldwide COLORADO SPRINGS, Colo. & SEATTLE, February 04, ...
Tasso, Inc. has completed a $6.1 million financing round led by Vertical Venture Partners (“VVP”), with participation from Techstars and Cedars-Sinai. This funding will help Tasso scale its first ...
The recent greenlight from European regulators to Tasso Inc. to market its Tasso+ device in the EU brings another solution to the market for blood collection Tasso has developed the Tasso+, a ...
Partnership combines Tasso's clinical grade blood collection solutions and ARUP's gold standard testing capabilities to streamline and accelerate decentralized clinical research SEATTLE and SALT LAKE ...
Tasso, Inc. (Tasso), Ceres Nanosciences (Ceres), George Mason University (Mason), and the United States Army Medical Research Institute of Infectious Diseases (USAMRIID) today announced the ...
Athlete-centric blood collection joint offering returns for its second Olympic Games as demand for modern anti-doping solutions intensifies worldwide Tasso, Inc., a leader in patient-centric blood ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results